GENERIC TIDE IS RISING Expiring patent protections and pressures on makers of brand-name drugs bode well for the generic pharmaceutical industr SQUEEZED A Quagmire Of European Patent Laws Creates Challenges For Generic Pharmaceutical Companies EVENTS HIGHLIGHT PHARMACEUTICAL DEVELOPMENT BEYOND HATCH-WAXMAN Legislative action seeks to close loopholes in U.S. law that delay entry of generics into the market GLOSSARY Defining The Terms Of The Hatch-Waxman Act GENERICS NEXT WAVE: BIOPHARMACEUTICALS With major biotech drugs coming off patent, generic drug makers are looking to compete PAYING ATTENTION TO UNMET NEEDS Start-up, nonprofits are developing tools to fight diseases afflicting poor nations